Is ibuprofen (Nonsteroidal Anti-Inflammatory Drug) or citalopram (Selective Serotonin Reuptake Inhibitor) advised for a patient who does not want to pursue medical treatment and is considering hospice care?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medication Management in Hospice Care

For a patient considering hospice care who does not want to pursue medical treatment, ibuprofen is preferred over citalopram as it directly addresses pain management, which is a primary concern in end-of-life care. 1, 2

Pain Management in Hospice Care

First-Line Approach

  • Ibuprofen is recommended as a first-line treatment for pain management in hospice patients 1
  • The National Comprehensive Cancer Network recommends NSAIDs like ibuprofen for initial pain management, with a maximum daily dose of 3200 mg 1
  • For patients with mild pain (1-3/10), acetaminophen and/or NSAIDs are the appropriate first step according to the WHO analgesic ladder 2

Special Considerations with Ibuprofen

  • Caution is required when using ibuprofen in patients at high risk for:
    • Renal toxicity (age >60, compromised fluid status, concomitant nephrotoxic drugs)
    • GI toxicity (age >60, history of peptic ulcer disease, alcohol use)
    • Cardiac toxicity (history of cardiovascular disease) 1
    • Bleeding disorders or thrombocytopenia 1

Monitoring and Management

  • If renal toxicity develops (BUN or creatinine doubles), discontinue ibuprofen 1
  • For GI upset, consider discontinuing or switching to a COX-2 inhibitor 1
  • Discontinue if liver function tests increase beyond three times the upper limit of normal 1

Why Citalopram is Not Preferred

  • Citalopram (an SSRI) is primarily indicated for depression, not pain management 1
  • While depression is common in end-of-life care, the American College of Physicians recommends addressing pain as a priority symptom 1
  • SSRIs may take up to 6 weeks to show effect, making them less suitable for immediate symptom management in hospice care 1
  • For patients at the end of life, focus should be on immediate symptom relief rather than long-term psychiatric management 2

Alternative Pain Management Options

Opioid Therapy

  • If pain is moderate to severe or unresponsive to NSAIDs, opioids are the mainstay of therapy 1, 2
  • Regular around-the-clock dosing with breakthrough dosing is recommended 2
  • A bowel regimen should be prescribed concurrently to prevent constipation 1

Non-Pharmacological Approaches

  • Consider complementary approaches such as:
    • Positioning and relaxation techniques 1
    • Physical therapy when appropriate 1
    • Heat or cold therapy 2

Addressing Other Common Hospice Symptoms

Dyspnea

  • Opioids are first-line treatment for unrelieved dyspnea 1, 2
  • Oxygen therapy for hypoxemia or subjective relief 1
  • Non-pharmacologic interventions: sitting upright, hand-held fans 1

Depression and Anxiety

  • For immediate relief of anxiety, benzodiazepines may be considered 2
  • For longer hospice stays where depression is a concern, sertraline has been studied extensively and appears to have a lower risk of QTc prolongation than citalopram 1

Common Pitfalls to Avoid

  • Inappropriate medication continuation: Discontinue medications that don't contribute to comfort 2
  • Undertreatment of pain: Regular assessment of pain is essential 1
  • Overreliance on as-needed (PRN) regimens: Adherence to PRN analgesic regimens is only about 51% 3
  • Ignoring patient preferences: About 30% of terminally ill patients may not want additional pain treatment despite experiencing pain 4

Remember that the goal of hospice care is to improve quality of life with a focus on comfort and symptom management. Pain control should be prioritized, making ibuprofen a more appropriate choice than citalopram for initial management in this setting.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Palliative Care Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Effect of hospice nonprofessional caregiver barriers to pain management on adherence to analgesic administration recommendations and patient outcomes.

Pain management nursing : official journal of the American Society of Pain Management Nurses, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.